The proliferation of colorectal cancer cells is suppressed by silencing of EIF3H

Bioscience, Biotechnology, and Biochemistry
Genhua YuLin Zhang

Abstract

Colorectal cancer is one of the most common causes of cancer-related deaths worldwide. Eukaryotic translation initiation factor 3, subunit H (EIF3H) is a subunit of EIF3, which is involved in mRNA recruitment and ribosomal complex disassembly and is known to be a driver of cell proliferation and survival in cancer. To investigate its function in colorectal cancer, the Oncomine database was used to evaluate the expression of EIF3H in human colorectal cancer and normal tissues. Then, we constructed a Lentivirus shorthair EIF3H vector (Lv-shEIF3H) to silence EIF3H expression in the colorectal cancer cell lines HCT116 and SW1116. We observed impaired cell growth and colony formation in these silenced cell lines. In addition, we showed that EIF3H knock-down led to cell apoptosis. In conclusion, EIF3H plays key roles in the apoptosis in colorectal cancer cells, which suggests EIF3H as a potential diagnostic biomarker in colorectal cancer.

References

Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M TsujiiR N DuBois
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauri AaltonenRichard Houlston
Mar 16, 2007·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
May 29, 2007·Nature·Douglas F EastonBruce A J Ponder
Jul 20, 2007·International Journal of Colorectal Disease·Michael OberwalderHannes M Müller
Oct 16, 2007·Current Opinion in Chemical Biology·James T Heeres, Paul J Hergenrother
Dec 19, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Hongzhi ZouDavid A Ahlquist
Jun 12, 2008·The Journal of Biological Chemistry·Lili ZhangJohn W B Hershey
Apr 8, 2009·International Journal of Cancer. Journal International Du Cancer·Rachel R HuxleyMark Woodward
Apr 21, 2009·Breast Cancer Research and Treatment·J E OlsonF J Couch
Jun 10, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Melissa M CenterElizabeth Ward
Mar 25, 2010·Nature Reviews. Cancer·Deborah SilveraRobert J Schneider
May 29, 2010·Breast Cancer Research and Treatment·J E OlsonF J Couch
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jun 28, 2011·Advances in Cancer Research·Gemma L Kelly, Andreas Strasser
Jul 16, 2011·Human Genetics·Ulrike PetersGraham Casey
Jan 29, 2013·Cellular and Molecular Life Sciences : CMLS·Roberta MarchioneJean-Luc Lenormand
Mar 19, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jun 15, 2014·Human Molecular Genetics·Kristen S PurringtonFergus J Couch
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Jan 30, 2021·Stem Cell Research & Therapy·Mengqi ChuXiaobo Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
Fluorescence microscopy
flow cytometry

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.